FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2052593622> ?p ?o ?g. }

• W2052593622 endingPage "2032" @default.
• W2052593622 startingPage "2026" @default.
• W2052593622 abstract "With some advanced squamous cell carcinomas (SCCs) of the head and neck, chemoradiation therapy may obviate the need for surgical intervention. However, both modalities are known to produce organ toxicities, and tumor insensitivity remains problematic. Thus there is a clear need for the development of new treatment strategies. Accordingly, preclinical studies to evaluate the use of valrubicin, a contact-safe, mechanistically novel antitumor agent, combined with low-dose radiation for the therapy of SCC have been conducted.The comparative in vitro antitumor activities of valrubicin with or without irradiation versus cisplatin were evaluated using human-derived sensitive and cisplatin-resistant SCC cell lines. A hamster cheek pouch model of SCC was used to assess the efficacy of weekly intratumoral valrubicin injections with and without concurrent low-dose irradiation.Valrubicin cytotoxicity was found to be comparable in both sensitive and platinum-resistant cell lines and superior to cisplatin. The addition of minimally cytotoxic cell irradiation (300-450 cGy) resulted in prolonged G2/M cell cycle arrest and a supraadditive increase in apoptotic cell death. In hamsters, once a week x 3 intratumoral drug injections (3, 6, or 9 mg) were growth inhibitory; however, when valrubicin (6 mg) was combined with minimally cytotoxic irradiation (150, 250, or 350 cGy) significant tumor shrinkage was observed.Valrubicin produces supra-additive effects against SCC when combined with low-dose irradiation. This effect appears to correlate with the ability of valrubicin, a cytoplasmic-localizing drug, to inhibit protein kinase C. Therapeutic use of valrubicin against SCC could provide for reduced radiation doses with consequent improved efficacy and reduction in host toxicity." @default.
• W2052593622 created "2016-06-24" @default.
• W2052593622 creator A5002644237 @default.
• W2052593622 creator A5016416819 @default.
• W2052593622 creator A5026465180 @default.
• W2052593622 creator A5048362751 @default.
• W2052593622 creator A5054681222 @default.
• W2052593622 creator A5068378134 @default.
• W2052593622 creator A5084544109 @default.
• W2052593622 creator A5085578226 @default.
• W2052593622 creator A5091753781 @default.
• W2052593622 date "2000-12-01" @default.
• W2052593622 modified "2023-09-26" @default.
• W2052593622 title "Rationale for Intralesional Valrubicin in Chemoradiation of Squamous Cell Carcinoma of the Head and Neck" @default.
• W2052593622 cites W1976011193 @default.
• W2052593622 cites W2009547965 @default.
• W2052593622 cites W2010847547 @default.
• W2052593622 cites W2018489324 @default.
• W2052593622 cites W2023288925 @default.
• W2052593622 cites W2037539296 @default.
• W2052593622 cites W2043513834 @default.
• W2052593622 cites W2084658541 @default.
• W2052593622 cites W2396428401 @default.
• W2052593622 cites W3039052488 @default.
• W2052593622 doi "https://doi.org/10.1097/00005537-200012000-00009" @default.
• W2052593622 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11129014" @default.
• W2052593622 hasPublicationYear "2000" @default.
• W2052593622 type Work @default.
• W2052593622 sameAs 2052593622 @default.
• W2052593622 citedByCount "9" @default.
• W2052593622 countsByYear W20525936222012 @default.
• W2052593622 countsByYear W20525936222015 @default.
• W2052593622 countsByYear W20525936222017 @default.
• W2052593622 countsByYear W20525936222022 @default.
• W2052593622 crossrefType "journal-article" @default.
• W2052593622 hasAuthorship W2052593622A5002644237 @default.
• W2052593622 hasAuthorship W2052593622A5016416819 @default.
• W2052593622 hasAuthorship W2052593622A5026465180 @default.
• W2052593622 hasAuthorship W2052593622A5048362751 @default.
• W2052593622 hasAuthorship W2052593622A5054681222 @default.
• W2052593622 hasAuthorship W2052593622A5068378134 @default.
• W2052593622 hasAuthorship W2052593622A5084544109 @default.
• W2052593622 hasAuthorship W2052593622A5085578226 @default.
• W2052593622 hasAuthorship W2052593622A5091753781 @default.
• W2052593622 hasBestOaLocation W20525936221 @default.
• W2052593622 hasConcept C126322002 @default.
• W2052593622 hasConcept C142724271 @default.
• W2052593622 hasConcept C143998085 @default.
• W2052593622 hasConcept C1491633281 @default.
• W2052593622 hasConcept C154317977 @default.
• W2052593622 hasConcept C202751555 @default.
• W2052593622 hasConcept C2776530083 @default.
• W2052593622 hasConcept C2776694085 @default.
• W2052593622 hasConcept C2776833033 @default.
• W2052593622 hasConcept C2778239845 @default.
• W2052593622 hasConcept C2778575167 @default.
• W2052593622 hasConcept C34439696 @default.
• W2052593622 hasConcept C502942594 @default.
• W2052593622 hasConcept C509974204 @default.
• W2052593622 hasConcept C54355233 @default.
• W2052593622 hasConcept C55493867 @default.
• W2052593622 hasConcept C71924100 @default.
• W2052593622 hasConcept C86803240 @default.
• W2052593622 hasConcept C98274493 @default.
• W2052593622 hasConceptScore W2052593622C126322002 @default.
• W2052593622 hasConceptScore W2052593622C142724271 @default.
• W2052593622 hasConceptScore W2052593622C143998085 @default.
• W2052593622 hasConceptScore W2052593622C1491633281 @default.
• W2052593622 hasConceptScore W2052593622C154317977 @default.
• W2052593622 hasConceptScore W2052593622C202751555 @default.
• W2052593622 hasConceptScore W2052593622C2776530083 @default.
• W2052593622 hasConceptScore W2052593622C2776694085 @default.
• W2052593622 hasConceptScore W2052593622C2776833033 @default.
• W2052593622 hasConceptScore W2052593622C2778239845 @default.
• W2052593622 hasConceptScore W2052593622C2778575167 @default.
• W2052593622 hasConceptScore W2052593622C34439696 @default.
• W2052593622 hasConceptScore W2052593622C502942594 @default.
• W2052593622 hasConceptScore W2052593622C509974204 @default.
• W2052593622 hasConceptScore W2052593622C54355233 @default.
• W2052593622 hasConceptScore W2052593622C55493867 @default.
• W2052593622 hasConceptScore W2052593622C71924100 @default.
• W2052593622 hasConceptScore W2052593622C86803240 @default.
• W2052593622 hasConceptScore W2052593622C98274493 @default.
• W2052593622 hasIssue "12" @default.
• W2052593622 hasLocation W20525936221 @default.
• W2052593622 hasLocation W20525936222 @default.
• W2052593622 hasOpenAccess W2052593622 @default.
• W2052593622 hasPrimaryLocation W20525936221 @default.
• W2052593622 hasRelatedWork W162241083 @default.
• W2052593622 hasRelatedWork W1975562877 @default.
• W2052593622 hasRelatedWork W2045018354 @default.
• W2052593622 hasRelatedWork W2110125130 @default.
• W2052593622 hasRelatedWork W2141904859 @default.
• W2052593622 hasRelatedWork W2161046978 @default.
• W2052593622 hasRelatedWork W2313027913 @default.
• W2052593622 hasRelatedWork W2414041517 @default.
• W2052593622 hasRelatedWork W2418089200 @default.
• W2052593622 hasRelatedWork W2460868461 @default.

• next